DC Chemicals

All products / DC20699

AT-130
CAT. NO. DC20699

AT-130

Pack sizes and prices

Pack sizePrice
100 mg$750 USDRequest a quote →
250 mg$1,350 USDRequest a quote →
1 g$2,550 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

AT-130 is a potent inhibitor of HBV capsid assembly, inhibits wild-type HBV replication with IC50 of 2.4 uM; inhibits replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro with same sensitivity (rtL180M, rtM204I, and rtL180M + rtM204V); blocks HBV replication at the level of viral RNA packaging, interferes with capsid morphogenesis, shows activity against the main lamivudine- and adefovir-resistant mutants.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC20699
Product nameAT-130
CAS211364-06-6
Molecular formulaC22H22N3O5Br
Molecular weight488.33118
Purity>98%
SMILESCOC1=C(C=CC=C1)C(/Br)=C(/NC(=O)C2=CC=C([N+](=O)[O-])C=C2)C(=O)N3CCCCC3

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — AT-130 (DC20699)

Source references

References 1. Delaney WE 4th, et al. Antimicrob Agents Chemother. 2002 Sep;46(9):3057-60. 2. Feld JJ, et al. Antiviral Res. 2007 Nov;76(2):168-77. 3. Billioud G, et al. Antiviral Res. 2011 Nov;92(2):271-6. View Related Products by Target HBV

Related research products